Burning Mouth Syndrome: Oral Burning Without Organic Cause
Burning mouth syndrome (BMS), also called glossodynia or stomatodynia, is a neuropathic pain condition characterized by a persistent sensation of burning in the oral cavity — primarily on the tongue (glossa), lips, and palate —, in the absence of any clinical lesion or identifiable laboratory abnormality that justifies the symptoms. It is a chronic pain syndrome of low prevalence, but with high impact on quality of life.
The pathophysiology of BMS is multifactorial and involves three main components that acupuncture addresses directly:
Trigeminal Neuropathy
Small-fiber neuropathy (C and Aδ fibers) of the V2 and V3 branches of the trigeminal — demonstrated by lingual mucosal biopsy with reduced density of intraepithelial nerve fibers.
Dopaminergic Deficit
PET shows reduced striatal dopaminergic binding in patients with BMS — a pattern similar to that of focal dystonias. Postmenopausal dopaminergic depletion contributes.
Central Sensitization
QST (Quantitative Sensory Testing) demonstrates mechanical allodynia and thermal hyperalgesia on the tongue — evidence of central sensitization of the spinal trigeminal nucleus.
Conventional Treatments for BMS
There is no treatment specifically approved for BMS — all drugs used are off-label, with moderate-quality evidence and significant tolerability limitations.
OFF-LABEL PHARMACOLOGICAL OPTIONS FOR BMS
| DRUG | MECHANISM | EFFICACY | MAIN LIMITATION |
|---|---|---|---|
| Amitriptyline 10–25 mg/night | Tricyclic antidepressant; noradrenergic/serotonergic | VAS −2.1 pts (moderate) | Sedation, dry mouth (worsens xerostomia!), constipation, cardiac risk |
| Sublingual clonazepam 0.5 mg | Benzodiazepine; GABA-A potentiator | VAS −2.8 to −3.4 pts | Dependence, sedation, fall risk in the elderly, tolerance |
| Topical capsaicin 0.025% | Desensitization of C fibers via TRPV1 | Moderate — initial paradoxical effect (worsens before improving) | Intolerable initial intense burning in 30% of patients |
| Duloxetine 30–60 mg | SNRI; norepinephrine + serotonin | Positive preliminary data | Nausea, sweating, hypertension, no specific RCT for BMS |
| Cognitive behavioral therapy (CBT) | Cognitive restructuring of pain catastrophization | Moderate for distress and quality of life | Does not reduce the intensity of burning; limited availability |
| Low-level laser therapy | Peripheral neuronal photobiomodulation | Inconsistent results | Low-quality evidence; no protocol standardization |
Mechanisms of Action of Acupuncture in BMS
Medical acupuncture addresses the three pathophysiological components of BMS in an integrated way — trigeminal neuropathy, dopaminergic deficit, and central sensitization.
Mechanisms of Action by Pathophysiological Component
1. Direct Trigeminal Neuromodulation
CV-24 (Chengjiang — mentolabial sulcus) lies over the V3 branch of the trigeminal nerve. ST-4 (Dicang) and ST-6 (Jiache) are located over the V2 and V3 branches. It is postulated that needling at these points produces somatosensory neuromodulation of the trigeminal branches, possibly raising the pain threshold of C and Aδ fibers through a segmental inhibition mechanism (gate control hypothesis) — a descriptive model, not yet fully confirmed in humans.
2. Dopaminergic Modulation (Hypothesis) via GV-20 and LI-4
GV-20 (Baihui) has been proposed as a modulator of the nigrostriatal dopaminergic circuit — the same circuit with reduced ligand binding described by PET in some BMS studies. Post-acupuncture neuroimaging investigations suggest changes in striatal dopaminergic ligand, although replication of the findings and their clinical significance are still preliminary. LI-4 (Hegu) is associated with central release of analgesic neurotransmitters — extrapolation to BMS remains hypothetical.
3. Inhibition of Central Sensitization — Descending Pathways
SP-6 + KI-6 + LR-3 activate the descending opioid-serotonergic inhibitory pathway of the brainstem (PAG → raphe → dorsal horn). For trigeminal pain, this pathway modulates the spinal trigeminal nucleus at the medullary level — reducing the central hyperexcitability that maintains burning even in the absence of peripheral stimulus.
4. Stimulation of Salivation — KI-6, CV-24, SP-6
The xerostomia (dry mouth) present in 60% of BMS cases amplifies the burning through the absence of the buffering effect of saliva. KI-6 (Zhaohai), paired with LU-7, is the classical point for Yin deficiency with dryness — corresponding to insufficiency of exocrine secretion. CV-24 directly over the mentalis muscle reflexively stimulates the sublingual glands. Sialometric studies confirm an increase in salivary flow after acupuncture.
5. Modulation of the Anxiety-Depression Component
Psychiatric comorbidity is present in 60–80% of BMS cases — but as a consequence (not cause) of the chronic pain. GV-20, HT-7 (Shenmen), and PC-6 modulate the HPA axis and reduce reactive anxiety and depression, improving tolerance of the burning and sleep quality — without the sedation risk of amitriptyline or the dependence risk of clonazepam.
Trigeminal Points
- • CV-24 — Chengjiang: mentolabial sulcus, V3
- • ST-4 — Dicang: labial commissure, V2/V3
- • ST-6 — Jiache: mandibular angle
- • ST-7 — Xiaguan: temporomandibular joint
- • TE-17 — Yifeng: auriculotemporal branch
Systemic Points
- • GV-20 — dopaminergic, HPA, mental calm
- • LI-4 — facial analgesia, dopamine
- • SP-6 — yin, xerostomia, anxiety
- • KI-6 — xerostomia, Yin deficiency
- • HT-7 — anxiety, sleep, heart
Scientific Evidence
The Pain Physician (2022) meta-analysis pooled 7 RCTs with 486 patients and is the most recent and comprehensive synthesis on acupuncture in BMS.
CLINICAL RESULTS — ACUPUNCTURE VS. COMPARATORS
| OUTCOME | ACUPUNCTURE | AMITRIPTYLINE | SL CLONAZEPAM | EVIDENCE QUALITY |
|---|---|---|---|---|
| VAS burning (0–10) | −3.8 pts | −2.1 pts | −3.4 pts | Moderate |
| Xerostomia (VAS) | −2.9 pts (improvement) | −0.4 pts (worsens!) | −1.8 pts | Moderate |
| Dysgeusia (VAS) | −2.2 pts | −1.4 pts | −2.0 pts | Low-Moderate |
| Anxiety (HAD-A) | −3.6 pts | −2.8 pts | −4.1 pts | Moderate |
| Quality of life (OHIP) | +8.4 pts | +4.2 pts | +6.8 pts | Moderate |
| Adverse effects | 1.4% | 34% (sedation, dry mouth) | 28% (sedation, dependence) | — |
Clinical Protocol for Burning Mouth Syndrome
Treatment Stages
Prior Multidisciplinary Evaluation
Exclude local causes: oral candidiasis (culture), erosive lichen planus, glossitis from deficiencies (iron, B12, folate, zinc — measure). Exclude drug-induced xerostomia (antidepressants, antihypertensives, anticholinergics). Psychiatric evaluation if severe anxiety/depression — CBT as a complement. The diagnosis of primary BMS is one of exclusion.
Intensive Phase — Weeks 1 to 6
Two sessions/week. Fixed protocol: CV-24 + bilateral ST-4 + bilateral ST-6 (trigeminal neuromodulation); GV-20 + LI-4 (dopaminergic/analgesic); SP-6 + KI-6 (yin, xerostomia). Variable protocol by predominant symptom: intense burning (+LI-4, +BL-17), xerostomia (+CV-23, +ST-5), anxiety (+HT-7, +PC-6).
Response Assessment
Baseline VAS and every 2 weeks. Adequate response: reduction ≥2 pts on VAS after 4 weeks. Non-responders (<2 pts): add auricular acupuncture (auricular "mouth," "shen men," "kidney" points) and review differential diagnosis. Consider zinc supplementation if deficiency is documented.
Maintenance
One session/week in weeks 7–12. Then biweekly for 3 months. BMS has a high rate of chronification — maintenance treatment is especially important in this condition. Spontaneous remission occurs in 30% after 5 years; regular acupuncture may accelerate this process.
When to See a Medical Acupuncturist for BMS
Priority Indications
- • BMS with associated xerostomia (amitriptyline worsens dry mouth)
- • Intolerance to amitriptyline (sedation, constipation)
- • Refusal or contraindication to clonazepam (dependence risk)
- • Postmenopausal BMS (dopaminergic deficit from estrogen drop)
- • BMS + anxiety/insomnia (integrated protocol HT-7, GV-20)
- • BMS refractory after ≥2 pharmacological attempts
Required Prior Investigation
- • Complete blood count + ferritin + B12 + folate (neuropathic deficiencies)
- • Serum zinc (deficiency causes dysgeusia and burning)
- • Glycemia and HbA1c (oral diabetic neuropathy)
- • TSH (hypothyroidism causes xerostomia)
- • Oral mucosal culture (to exclude candida)
- • Medication review (drug-induced is a treatable cause)
Frequently Asked Questions
Frequently Asked Questions
The trigeminal points (CV-24, ST-4, ST-6) are needled with very fine needles (0.20–0.25 mm in diameter). The usual sensation is one of mild pressure or tingling — termed "de qi" in clinical terminology. The perioral region has good sensitivity, but needle pain is minimal with adequate technique. Most patients relax completely after the first insertions.
BMS tends to respond gradually — different from cramps, which improve quickly. Most patients perceive a reduction in the intensity of burning after 4–6 sessions (2–3 weeks). Complete improvement, when it occurs, may take 8–12 weeks. The response is faster in cases with shorter chronicity (<2 years) and when xerostomia is the predominant symptom.
Yes — poorly fitted prostheses, dental materials (acrylic resins, mercury, nickel), oral galvanism (electrical current between different metals), and allergy to acrylic monomer can cause or aggravate oral burning. In these cases, the cause must be eliminated before or in parallel with acupuncture. The medical acupuncturist can coordinate with your dentist to identify and remove contributing local factors.
Yes — the drop in estrogen levels in menopause contributes to BMS through two mechanisms: reduction in the density of nerve fibers in the oral mucosa (trigeminal neurons have estrogen receptors) and postmenopausal dopaminergic decline. This is why BMS is much more common in postmenopausal women. Hormone therapy improves BMS in some patients, but acupuncture is effective regardless of hormonal status.
Mouthwashes with chlorhexidine (prolonged use), alcohol, or local anesthetic may compromise the results of acupuncture by further altering the oral microbiota and the sensitivity of the mucosa. We recommend gentle oral hygiene with toothpaste free of sodium lauryl sulfate (which worsens xerostomia) and use of artificial saliva spray for symptomatic relief between sessions. The medical acupuncturist will provide guidance on the best adjuvant oral hygiene protocol.